These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 15943482)

  • 1. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
    J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.
    Pettit GR; Toki BE; Herald DL; Boyd MR; Hamel E; Pettit RK; Chapuis JC
    J Med Chem; 1999 Apr; 42(8):1459-65. PubMed ID: 10212132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
    J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
    Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
    J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
    Borrel C; Thoret S; Cachet X; Guénard D; Tillequin F; Koch M; Michel S
    Bioorg Med Chem; 2005 Jun; 13(11):3853-64. PubMed ID: 15863010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
    Pettit GR; Anderson CR; Herald DL; Jung MK; Lee DJ; Hamel E; Pettit RK
    J Med Chem; 2003 Feb; 46(4):525-31. PubMed ID: 12570374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
    J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J; Pontikis R; Florent JC; Monneret C
    Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
    Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
    J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
    Pettit GR; Thornhill A; Melody N; Knight JC
    J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
    O'Boyle NM; Carr M; Greene LM; Bergin O; Nathwani SM; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
    J Med Chem; 2010 Dec; 53(24):8569-84. PubMed ID: 21080725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic agents 365. Dolastatin 10 SAR probes.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
    Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design.
    Sun L; Vasilevich NI; Fuselier JA; Hocart SJ; Coy DH
    Bioorg Med Chem Lett; 2004 May; 14(9):2041-6. PubMed ID: 15080975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
    Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
    J Med Chem; 1997 Jul; 40(14):2266-75. PubMed ID: 9216846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
    Pettit GR; Rhodes MR; Herald DL; Chaplin DJ; Stratford MR; Hamel E; Pettit RK; Chapuis JC; Oliva D
    Anticancer Drug Des; 1998 Dec; 13(8):981-93. PubMed ID: 10335271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.